You are here

opiods

Drug distributor that paid $20M fine exits opioid sales because of costs of legal risks

Drug distributor that paid $20M fine exits opioid sales because of costs of legal risks

Fierce Pharma

Rochester Drug Co-operative

Flag link:

J&J kicks back at Oklahoma politicians' move to squeeze out more opioid payments: report

J&J kicks back at Oklahoma politicians' move to squeeze out more opioid payments: report

Fierce Pharma

Flag link:

Healthcare on the Hill - a bill that would classify all opioid mu receptor agonists schedule I (H.R.5298)

Healthcare on the Hill

Flag link:

FDA finalizes opioid guidance

FDA finalizes opioid guidance

Medical Marketing and Media

Flag link:

Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)

Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)

Yahoo/BusinessWire

pain management

Flag link:

Zogenix Receives FDA Approval of New Formulation of Zohydro(R) ER

Zogenix Receives FDA Approval of New Formulation of Zohydro(R) ER

Yahoo/Globe NewsWire

pain management

Flag link:

Nektar Fortifies Its Position In Advance Of The Rescheduled FDA Panel On OIC

Nektar Fortifies Its Position In Advance Of The Rescheduled FDA Panel On OIC

Seeking Alpha

opiod-induced constipation

Flag link:

Let's Get the Facts Straight About Zohydro ER--and the Important Patient Need It Fills

Let's Get the Facts Straight About Zohydro ER--and the Important Patient Need It Fills

Yahoo/PR NewsWire

pain management

Flag link:

2 senators investigate Zohydro OK

2 senators investigate Zohydro OK

American Live Wire

pain management

Flag link:

FDA ratchets up requirements on long-acting, extended-release opioids

FDA ratchets up requirements on long-acting, extended-release opioids

Fierce Pharma

Flag link:

Zalicus May Have Long-Term Value, But What's Behind Exalgo's Weakness?

Zalicus May Have Long-Term Value, But What's Behind Exalgo's Weakness?

Seeking Alpha

Flag link:

FDA Heightens Painkiller Oversight

FDA Heightens Painkiller Oversight

WSJ Online

Flag link:

Covidien, Zalicus drugs hit by new federal 'opioid strategy'

Covidien, Zalicus drugs hit by new federal 'opioid strategy'

Bizjournals.com

Flag link:

Covidien Supports FDA on Long-Acting Opioid REMS

Covidien Supports FDA on Long-Acting Opioid REMS

Flag link:

Nektar starts trial on next-generation opioid

Nektar starts trial on next-generation opioid

Bizjournals.com

Flag link:

Nektar Announces Two Preclinical Data Presentations at Society for Neuroscience 40th Annual Meeting: Neuroscience 2010

Nektar Announces Two Preclinical Data Presentations at Society for Neuroscience 40th Annual Meeting: Neuroscience 2010

Yahoo/PR NewsWire

pain management

abuse-resistant painkillers

Flag link:

Aoxing Pharmaceutical Company and Phoenix PharmaLabs, Inc. Announce Strategic Alliance to Co-Develop a Novel Class of Molecules in Pain and Drug Addiction Therapeutics

Aoxing Pharmaceutical Company and Phoenix PharmaLabs, Inc. Announce Strategic Alliance to Co-Develop a Novel Class of Molecules in Pain and Drug Addiction Therapeutics

Pipeline Review

Phoenix PharmaLabs

pain management

Flag link:

King Announces Commercial Availability of EMBEDA(TM)

King Announces Commercial Availability of EMBEDA(TM)

Yahoo

Flag link:

FDA's "secret" opioid REMS meeting

FDA's "secret" opioid REMS meeting

InVivo

Flag link: